• 1
    Los Arcos-Bertiz I, Santos-Ortega A, Rodriguez Palomares J, Juanos-Iborra M, Bujan-Rivas S, Tornos-Mas P, et al. A 72-year-old man with dyspnea, circumferential aortic thickening, and weight loss. Arthritis Care Res (Hoboken) 2013;65:205661.
  • 2
    Arnaud L, Hervier B, Neel A, Hamidou MA, Kahn JE, Wechsler B, et al. CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 2011;117:277882.
  • 3
    Mazor RD, Manevich-Mazor M, Shoenfeld Y. Erdheim-Chester Disease: a comprehensive review of the literature. Orphanet J Rare Dis 2013;8:137.
  • 4
    Rahman MA, Salajegheh A, Smith RA, Lam AK. B-Raf mutation: a key player in molecular biology of cancer. Exp Mol Pathol 2013;95:33642.
  • 5
    Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood 2013;121:1495500.
  • 6
    Emile JF, Charlotte F, Amoura Z, Haroche J. BRAF mutations in Erdheim-Chester disease (letter).J Clin Oncol 2013;31:398.